T1	Participants 501 571	patients with BRAF(V600E/K) advanced melanoma treated with vemurafenib
T2	Participants 593 768	Formalin-fixed tissue blocks were obtained of tumours from patients enrolled in the BRIM2 (n = 59) and BRIM3 (n = 150) trials of vemurafenib in advanced BRAF(V600E/K) melanoma
